» Articles » PMID: 25482601

Prion Formation, but Not Clearance, is Supported by Protein Misfolding Cyclic Amplification

Overview
Journal Prion
Specialty Biochemistry
Date 2014 Dec 9
PMID 25482601
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Prion diseases are fatal transmissible neurodegenerative disorders that affect animals including humans. The kinetics of prion infectivity and PrP(Sc) accumulation can differ between prion strains and within a single strain in different tissues. The net accumulation of PrP(Sc) in animals is controlled by the relationship between the rate of PrP(Sc) formation and clearance. Protein misfolding cyclic amplification (PMCA) is a powerful technique that faithfully recapitulates PrP(Sc) formation and prion infectivity in a cell-free system. PMCA has been used as a surrogate for animal bioassay and can model species barriers, host range, strain co-factors and strain interference. In this study we investigated if degradation of PrP(Sc) and/or prion infectivity occurs during PMCA. To accomplish this we performed PMCA under conditions that do not support PrP(Sc) formation and did not observe either a reduction in PrP(Sc) abundance or an extension of prion incubation period, compared to untreated control samples. These results indicate that prion clearance does not occur during PMCA. These data have significant implications for the interpretation of PMCA based experiments such as prion amplification rate, adaptation to new species and strain interference where production and clearance of prions can affect the outcome.

Citing Articles

Evidence for preexisting prion substrain diversity in a biologically cloned prion strain.

Gunnels T, Shikiya R, York T, Block A, Bartz J PLoS Pathog. 2023; 19(9):e1011632.

PMID: 37669293 PMC: 10503715. DOI: 10.1371/journal.ppat.1011632.


Efficient interspecies transmission of synthetic prions.

Block A, Shikiya R, Eckland T, Kincaid A, Walters R, Ma J PLoS Pathog. 2021; 17(7):e1009765.

PMID: 34260664 PMC: 8312972. DOI: 10.1371/journal.ppat.1009765.


Cellular and Molecular Mechanisms of Prion Disease.

Sigurdson C, Bartz J, Glatzel M Annu Rev Pathol. 2018; 14:497-516.

PMID: 30355150 PMC: 9071098. DOI: 10.1146/annurev-pathmechdis-012418-013109.


PrPSc formation and clearance as determinants of prion tropism.

Shikiya R, Langenfeld K, Eckland T, Trinh J, Holec S, Mathiason C PLoS Pathog. 2017; 13(3):e1006298.

PMID: 28355274 PMC: 5386299. DOI: 10.1371/journal.ppat.1006298.


Prion Strain Diversity.

Bartz J Cold Spring Harb Perspect Med. 2016; 6(12).

PMID: 27908925 PMC: 5131755. DOI: 10.1101/cshperspect.a024349.


References
1.
Bessen R, Marsh R . Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J Virol. 1992; 66(4):2096-101. PMC: 289000. DOI: 10.1128/JVI.66.4.2096-2101.1992. View

2.
Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H, DeArmond S . Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992; 356(6370):577-82. DOI: 10.1038/356577a0. View

3.
Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y . Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 1996; 379(6563):339-43. DOI: 10.1038/379339a0. View

4.
Beekes M, Baldauf E, Diringer H . Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J Gen Virol. 1996; 77 ( Pt 8):1925-34. DOI: 10.1099/0022-1317-77-8-1925. View

5.
Lasmezas C, Deslys J, Demaimay R, Adjou K, Hauw J, Dormont D . Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J Gen Virol. 1996; 77 ( Pt 7):1601-9. DOI: 10.1099/0022-1317-77-7-1601. View